Lirucitinib
Lirucitinib is a JAK inhibitor, and has antiinflammatory activity[1]
Product Specifications
CAS Number
[2458115-78-9]
UNSPSC
12352005
Target
JAK
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CN([C@@H](CC1)CC[C@H]1C[S@](CC)(=N)=O)C2=C(C=CN3)C3=NC=N2
Molecular Formula
C16H25N5OS
Molecular Weight
335.47
References & Citations
[1]WHO Drug Information, Vol. 38 , No. 4, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043252-ML550 100 µL
TRIM56, CT (TRIM56, RNF109, E3 ubiquitin-protein ligase TRIM56, RING finger protein 109, Tripartite motif-containing protein 56) (MaxLight 550) discontinued
Ask
View Details MBS6491498-01 0.1 mL
p53 (S315) (Cellular Tumor Antigen p53, Tumor Suppressor p53, Phosphoprotein p53, Antigen NY-CO-13, TP53, P53) (MaxLight 405)
Ask
View Details